FIELD: medicine.
SUBSTANCE: invention relates to medicine and is intended for the differential diagnosis of high duodenogastroesophageal, acid, weak acid and weak alkaline refluxes. Collect unstimulated mixed saliva of the patient, determine the total and direct bilirubin, with the values of total bilirubin in the saliva 2.36–2.91 mcmol/l and direct bilirubin 1.39–2.31 mcmol/l determine the absence of high gastroesophageal refluxes; with the values of total bilirubin of 2.92–3.18 mcmol/l and direct bilirubin of 2.45–2.64 mcmol/l – the weak acid nature of refluxate; total bilirubin 3.19–3.60 mcmol/l and direct bilirubin 2.32–2.44 mcmol/l – the acid nature of the refluxate; total bilirubin 3.61 mcmol/l and more and direct bilirubin 2.65 mcmol/l and more – weak alkaline nature of refluxate.
EFFECT: method allows to increase the efficiency of differential diagnosis of GERD.
1 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DIAGNOSING HIGH GASTROESOPHAGEAL REFLUXES | 2017 |
|
RU2659955C1 |
METHOD OF DIAGNOSTICS OF THE BARRETT ESOPHAGUS IN PATIENTS WITH COMPLICATIONS FROM GASTROESOPHAGEAL REFLUX DISEASE | 2017 |
|
RU2655807C1 |
METHOD FOR NON-INVASIVE DIAGNOSIS OF GASTROESOPHAGEAL REFLUX DISEASE PHENOTYPES | 2020 |
|
RU2725603C1 |
METHOD FOR DETERMINING ALKALINE INGREDIENT AVAILABILITY IN REFLUXATE IN GASTROESOPHAGEAL REFLUX CASES CAUSED BY STOMACH RESECTION INTERVENTIONS | 2005 |
|
RU2310847C2 |
METHOD OF COMPLEX TREATMENT OF GASTROESOPHAGEAL DISEASE IN PATIENTS WITH OPISTHORCHOSIS | 2010 |
|
RU2420294C1 |
DIAGNOSTIC TECHNIQUE FOR GASTROESOPHAGEAL REFLUX DISEASE | 2012 |
|
RU2543346C2 |
METHOD FOR ASSESSING ANTIREFLUX EFFECT OF DRINKING MINERAL WATER IN CASE OF GASTROESOPHAGEAL REFLUX DISEASE | 2022 |
|
RU2801416C1 |
METHOD FOR TREATING DUODENOGASTROESOPHAGEAL REFLUX DISEASE | 2019 |
|
RU2695067C1 |
METHOD FOR PREDICTION OF CLINICAL COURSE OF GASTROESOPHAGEAL REFLUX DISEASE | 2012 |
|
RU2530634C2 |
DIAGNOSTIC TECHNIQUE FOR EROSIOGENIC ACTIVITY OF ORAL FLUID IN PATIENTS SUFFERING FROM OESOPHAGEAL ORAL REFLUX ACCOMPANYING GASTROESOPHAGEAL REFLUX DISEASE | 2012 |
|
RU2533561C2 |
Authors
Dates
2018-11-08—Published
2018-02-14—Filed